Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetic basis and molecular profiling in myeloproliferative neoplasms
Damien Luque Paz, Róbert Královics, Radek C. Skoda
Blood (2022) Vol. 141, Iss. 16, pp. 1909-1921
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

Neutrophil-to-lymphocyte ratio and all-cause mortality with and without myeloproliferative neoplasms—a Danish longitudinal study
Morten Kranker Larsen, Vibe Skov, Lasse Kjær, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 13
The prognostic contribution of CBL, NRAS, KRAS, RUNX1, and TP53 mutations to mutation‐enhanced international prognostic score systems (MIPSS70/plus/plus v2.0) for primary myelofibrosis
Giuseppe Gaetano Loscocco, Giada Rotunno, Francesco Mannelli, et al.
American Journal of Hematology (2023) Vol. 99, Iss. 1, pp. 68-78
Open Access | Times Cited: 16
Molecular Genetic Profile of Myelofibrosis: Implications in the Diagnosis, Prognosis, and Treatment Advancements
Tanvi Verma, Nikolaos Papadantonakis, Deniz Peker Barclift, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 514-514
Open Access | Times Cited: 5
Association of Myelofibrosis Phenotypes with Clinical Manifestations, Molecular Profiles, and Treatments
Helen T. Chifotides, Srđan Verstovšek, Prithviraj Bose
Cancers (2023) Vol. 15, Iss. 13, pp. 3331-3331
Open Access | Times Cited: 14
Recent Advances Towards the Understanding of Secondary Acute Myeloid Leukemia Progression
Scott S. Auerbach, Beana Puka, Upendarrao Golla, et al.
(2024)
Open Access | Times Cited: 4
Combined Effects of Clonal Hematopoiesis and Carotid Stenosis on Cardiovascular Mortality
Roland Jäger, Matthias Hoke, Florian Mayer, et al.
Journal of the American College of Cardiology (2024) Vol. 83, Iss. 18, pp. 1717-1727
Closed Access | Times Cited: 4
Роль соматических мутаций в различных генах и проблема резистентности к ингибиторам тирозинкиназ у пациентов с хроническим миелолейкозом (обзор литературы)
Elena Kuzmina, Ekaterina Chelysheva, Bella Biderman, et al.
Clinical oncohematology (2025) Vol. 18, Iss. 1, pp. 10-20
Open Access
CALRins5-mediated clonal hematopoiesis causes severe hemolytic anemia in a female PGK1Ser320Asn carrier
María Luz Morales, Horacio Cano, Belén de la Morena‐Barrio, et al.
Blood Cancer Journal (2025) Vol. 15, Iss. 1
Open Access
A case report of donor cell-derived hematologic neoplasms 9 years after allogeneic hematopoietic cell transplantation
Aleksandra Mroczkowska-Bękarciak, Tomasz Wróbel
Oncotarget (2025) Vol. 16, Iss. 1, pp. 44-50
Open Access
CALR—mutant myeloproliferative neoplasms: insights from next-generation sequencing
Aleksandra Mroczkowska-Bękarciak, Agnieszka Szeremet, Olga Chyrko, et al.
Journal of Applied Genetics (2025)
Open Access
Spotlight on amino acid changing mutations in the JAK-STAT pathway: from disease-specific mutation to general mutation databases
Markus Hoffmann, Lothar Hennighausen
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Multiple Aneurysms and Thrombotic Events as Initial Manifestations of Primary Myelofibrosis: A Case Report
Konstantinos Manganas, Thrasyvoulos Bemplidakis, K. Papachristou, et al.
Cureus (2025)
Open Access
Genomic Profile Helps to Predict the Clonal Evolution and Outcome of Bcr-Abl-Negative Myeloproliferative Neoplasms
Xiaodong Guo, Wenbo Jia, Xinyu Yang, et al.
(2025)
Closed Access
Molecular characterization underlying IFN-α2 treatment in polycythemia vera: a transcriptomic overview
Fangfang Liu, Ke Li
Molecular and Cellular Biochemistry (2025)
Closed Access
Loss of Socs2 improves molecular responses to IFNα in a mouse model of myeloproliferative neoplasms driven by JAK2-V617F
Marc Usart, Quentin Kimmerlin, Jan Stetka, et al.
Leukemia (2025)
Closed Access
Chinese Patients With BCR::ABL1‐Negative Myeloproliferative Neoplasms: Immunophenotype of Myeloid Monocytes
Fengting Liang, Yu Zou, Lanxuan Huang, et al.
International Journal of Laboratory Hematology (2025)
Open Access
Immunosuppression of spleen in mice treated with erythropoietin: transcriptomic and immunological analysis
Xuanxin Lyu, Jiahao Shi, Qi Liu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Primary and secondary myelofibrosis: ophthalmological manifestations at onset and during therapy
Olga Vinogradova, L. B. Egoryan, Д. И. Шихбабаева, et al.
Oncohematology (2025) Vol. 20, Iss. 1, pp. 95-113
Open Access
Malignant JAK-signaling: at the interface of inflammation and malignant transformation
Florian Perner, Heike L. Pahl, Robert Zeiser, et al.
Leukemia (2025)
Open Access
Contribution of molecular characterization to the diagnosis of MPN in patients with low JAK2V617F variant allelic fraction in a real-world cohort
Benjamin Lebecque, Carolyne Croizier, Thomas Tassin, et al.
Annals of Hematology (2025)
Open Access
Myeloproliferative Neoplasms: Diseases Mediated by Chronic Activation of Signal Transducer and Activator of Transcription (STAT) Proteins
Clifford Liongue, Alister C. Ward
Cancers (2024) Vol. 16, Iss. 2, pp. 313-313
Open Access | Times Cited: 3
Proinflammatory phenotype of iPS cell-derived JAK2 V617F megakaryocytes induces fibrosis in 3D in vitro bone marrow niche
Niclas Flosdorf, Janik Böhnke, Marcelo A. S. Toledo, et al.
Stem Cell Reports (2024) Vol. 19, Iss. 2, pp. 224-238
Open Access | Times Cited: 3
Advances in Molecular Understanding of Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis: Towards Precision Medicine
Hammad Tashkandi, Ismail Elbaz Younes
Cancers (2024) Vol. 16, Iss. 9, pp. 1679-1679
Open Access | Times Cited: 3
Quantitative interpretation of bone marrow biopsies in MPN—What's the point in a molecular age?
Hosuk Ryou, Oliver Lomas, Helen Theissen, et al.
British Journal of Haematology (2023) Vol. 203, Iss. 4, pp. 523-535
Open Access | Times Cited: 8
Recent advances in therapies for primary myelofibrosis
William Vainchenker, Nasrine Yahmi, Violaine Havelange, et al.
Faculty Reviews (2023) Vol. 12
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top